SCHEMBL8905967

SCHEMBL8905967

[O]CCCCOCc1ccncc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 3/20 0.39
HRH4 Q9H3N8 2/20 0.39
GBA1 P04062 1/20 0.38
UGCG Q16739 1/20 0.38
GBA2 Q9HCG7 1/20 0.38
CYP17A1 P05093 1/20 0.37
CYP19A1 P11511 1/20 0.37
KDM4E B2RXH2 1/20 0.37
KMT2A Q03164 1/20 0.37
POLB P06746 1/20 0.36
LOXL2 Q9Y4K0 1/20 0.35
GRM5 P41594 2/20 0.35
TDP1 Q9NUW8 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
KEAP1 Q14145 1/20 0.35
NFE2L2 Q16236 1/20 0.35
ALDH1A1 P00352 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2D6 P10635 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14101264 0.86 LOXL2 (0.42) HRH3HRH4GBA1UGCGGBA2
SCHEMBL12743775 0.82 HRH1 (0.52) HRH3HRH4GBA1UGCGGBA2
SCHEMBL17132267 0.81 LOXL2 (0.46) HRH3HRH4CYP17A1CYP19A1KDM4E
SCHEMBL12743794 0.80 HRH1 (0.48) HRH3HRH4LOXL2TDP1L3MBTL1
SCHEMBL96048 0.80 TSHR (0.56) HRH3HRH4KMT2ATDP1L3MBTL1
SCHEMBL13610216 0.79 CYP3A4 (0.44) GBA1UGCGGBA2KDM4EKMT2A
SCHEMBL96808 0.78 L3MBTL1 (0.54) HRH3HRH4GBA1UGCGGBA2
SCHEMBL97794 0.78 L3MBTL1 (0.54) HRH3HRH4GBA1UGCGGBA2
SCHEMBL2569768 0.78 HRH1 (0.52) HRH3HRH4GBA1UGCGGBA2
Butane SCHEMBL29206935 0.78 LMNA (0.43) GBA1UGCGGBA2KDM4EKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5659065-A CHEMICAL INTERMEDIATES FOR MEDICINAL ACTIVE AGENTS NOVARTIS CORPORATION (US) 1997-08-19 US disclosed
EP-0678500-A1 Alpha-amino alkanoic acids and reduction products as intermediates in the preparation of renin inhibitors CIBA-GEIGY AG (CH) 1995-10-25 EP disclosed